RPRX

Repros Therapeutics Inc.
RPRX

Delisted

RPRX was delisted on the 31st of January, 2018.

80 hedge funds and large institutions have $379M invested in Repros Therapeutics Inc. in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 13 closing their positions.

Holders
80
Holders Change
+1
Holders Change %
+1.27%
% of All Funds
2.31%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
15
Increased
30
Reduced
16
Closed
13
Calls
$10.6M
Puts
$12.7M
Net Calls
-$2.11M
Net Calls Change
-$7.97M
Name Market Value Shares Shares
Change
Shares
Change %
KTC
76
Kistler-Tiffany Companies
Pennsylvania
$5K 270
TRCT
77
Tower Research Capital (TRC)
New York
$5K 308 +308 New
Creative Planning
78
Creative Planning
Kansas
$1K 50 +50 New
Manulife (Manufacturers Life Insurance)
79
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$315 17,727 -4 -0%
Jennison Associates
80
Jennison Associates
New York
-1,494,980 Closed
PC
81
PointState Capital
New York
-270,000 Closed
SFM
82
Sphera Funds Management
Israel
-120,000 Closed
CCA
83
Catalyst Capital Advisors
New York
-87,331 Closed
PA
84
Perceptive Advisors
New York
-71,879 Closed
Millennium Management
85
Millennium Management
New York
-64,100 Closed
JPMorgan Chase & Co
86
JPMorgan Chase & Co
New York
-54,391 Closed
JGC
87
J. Goldman & Co
New York
-45,000 Closed
LOM
88
Loeb Offshore Management
New York
-18,688 Closed
DS
89
DRW Securities
Illinois
-14,000 Closed
CNB
90
City National Bank
California
-12,200 Closed
ASN
91
Advisory Services Network
Georgia
-2,694 Closed
BNP Paribas Financial Markets
92
BNP Paribas Financial Markets
France
-297 Closed
ST
93
Spot Trading
Illinois
SM
94
Sabby Management
Florida
ID
95
Integral Derivatives
New York
Royal Bank of Canada
96
Royal Bank of Canada
Ontario, Canada
Ameriprise
97
Ameriprise
Minnesota
$0 10